UnitedHealth beats: reading the medical cost ratio

UnitedHealth Group reported third-quarter earnings on Tuesday that came in well above analyst estimates, and it raised its profit outlook for 2026, according to CNBC. The headline sounds simple, but the report holds a few numbers that pull in different directions. This article looks at which number drove the beat, what it means for a health insurer, and how to read it the next time a report like this lands.

The headline in plain words

UnitedHealth earned more in the quarter than Wall Street analysts had forecast. It also told investors it now expects adjusted earnings for fiscal 2026 of at least $20.50 per share. Its previous outlook was a range of $19.50 to $20 per share.

Notice the change in wording, not just the change in figures. An earlier range had a top and a bottom. The new guidance is a floor: at least $20.50. When a company moves from a range to a floor above the old top, it is signalling more confidence. It is still a company estimate, not a promise.

The number behind it: the medical cost ratio

For most companies, the number to watch is profit margin. For a health insurer, the key figure has its own name: the medical cost ratio. It compares what the insurer pays out for members' medical care with what it collects in premiums. If an insurer collects a dollar of premiums and spends most of it on care, the ratio is high and little is left for other costs and profit.

UnitedHealth's ratio was 88.4% for the quarter. Analysts had expected 89.9%, according to StreetAccount data cited by CNBC. Here, lower is better for the company. A lower ratio means more of each premium dollar was left after paying claims, which supports profit. So a result below the forecast is a positive surprise, even though the number itself went the other way.

Always ask which direction helps the company before you judge a beat or a miss.

Revenue fell, profit rose: how both can be true

Quarterly revenue came in at $112.69 billion, a little below the $113.16 billion of the prior-year quarter. Yet net income reached $4.11 billion, which works out to $4.56 for each share, against $2.35 billion and $2.59 per share in the same quarter last year.

Lower sales with higher profit is not a contradiction. It fits the plan CNBC described: the company is shrinking its membership and leaving contracts that lost money. Fewer members can mean fewer premiums, so revenue dips. But if the business that remains costs less to serve, more of each dollar turns into profit. This is why the cost ratio matters more than the top line for this report.

There is also a second earnings figure. Excluding items such as divestitures, restructuring and an expected cut to reserves set aside for money-losing contracts, the company's per-share profit was $4.69. That is the adjusted figure, and it is the one analysts usually compare with their estimates. The reported figure of $4.56 follows standard accounting rules. Read both, and check what was removed to get from one to the other.

What the company said, and its caveat

Both main units, the UnitedHealthcare insurance business and the Optum health services arm, beat analyst forecasts for operating earnings, per StreetAccount. CFO Wayne DeVeydt pointed to the turnaround steps, including more spending on value-based care, which pays doctors for outcomes rather than volume, and on AI tools.

He also gave numbers on how care is shifting. Through the third quarter, acute hospital admissions among members fell 15% year over year, while home health admissions rose 10%. Patient self-scheduled appointments rose 27%. He expects these programs to build on each other through the fourth quarter and into 2027.

But DeVeydt warned against reading the better ratio as a sign that medical costs are easing. He said costs remain high compared with historical norms. He pointed to a federal dispute process under the No Surprises Act, known as IDR, which he said adds 100 basis points or more to total medical costs. Inpatient care and specialty drugs for cancer and rare diseases are also still running high. "I think it's something we should keep an eye on," DeVeydt said, according to CNBC.

That caveat is the risk to keep in mind. A cost ratio can improve because of company choices, such as dropping costly contracts, while the underlying cost of care keeps rising. One quarter does not tell you which force will win.

How to check this yourself next time

When the next insurer reports, repeat this reading.

• Find the medical cost ratio, sometimes called the medical care ratio or medical loss ratio, and compare it with the analyst estimate, remembering that lower helps the insurer.
• Put reported and adjusted earnings per share side by side, and read the list of items the company excluded to get the adjusted number.
• Check whether guidance is a range or a floor, and compare it with the previous outlook, then read what management says about cost trends before treating a good ratio as a lasting change.

None of these steps tells you whether the shares are worth owning. They tell you what the report actually says, which is where any decision should start.

Sources

• CNBC, 13 Oct 2026

AI-drafted from the filings and reports above, then published automatically after checks that each number appears in a cited source and that no wording is copied. There was no human edit. Educational reading only, not a recommendation on any stock.